Global Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type (Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis), By Product Type, By End User, By Regional Outlook and Forecast, 2022 - 2028

The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period.

Interventional oncology (IO) is an emerging subspecialty that emphasizes on using image-guided processes (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care. The three key areas of cancer intervention that IO focuses on are diagnosis, therapy, and symptom relief. Improvements in cross-sectional imaging techniques such as ultrasound, computed tomography (CT), magnetic resonance (MR), and positron emission tomography (PET) have enabled progress in IO (PET).

Because of the rising number of cancer cases among individuals around the world, the interventional oncology market is expected to rise faster in the coming years. Cancer is one of the most rapidly developing health problems, impacting individuals of different ages. Breast cancer & throat cancer are two of the most common types of cancer in individuals. The need for technologically improved cancer management therapy has expanded in tandem with the rise in the number of cancer patients.

Patients with cancer, both adults and children, have benefited from the innovative interventional oncology therapy line. In the coming years, such advancements are expected to have a positive influence on interventional oncology market growth. IO, along with Medical, Surgical, and Radiation Oncology, has successfully established itself as a significant treatment specialism within multidisciplinary oncologic care. In today's cancer care, IO is currently regarded the fourth pillar. Though surgical removal of tumours is typically thought to be the greatest therapy, it is not always achievable owing to the tumor's size, quantity, or location. IO treatments can be used to reduce a tumour, allowing for surgery or interventional treatment. A few patients may be unable to endure open surgery due to their health.

COVID-19 Impact Analysis

Patients have constrained themselves from going to visit hospitals and clinics for diagnosis of medical problems other than coronavirus symptoms owing to the increase incidence of coronaviral transmission. As a result, fewer cancer patients have reported to hospitals for treatment. The market is confronted with production and supply chain problems, such as providing items to end users on time and catering to an inconsistent demand for the sector's products and services. Furthermore, a scarcity of talented lab experts to perform diagnostic tests, restricted operations in most businesses, insufficient financing for research & academic institutes, the temporary closure of main academic institutes, a disrupted supply chain, and obstacles in offering a service owing to lockdowns have all contributed to a decrease in the supply of interventional oncology products to end users. As a result, the pandemic is unlikely to have long-term consequences for the basic growth drivers or end consumers in the economy.

Market Growth Factors

More efficiency and quick recovery offered by interventional oncology

While utilizing medical imaging technologies during vascular therapies, radiologists & technologists have a lot of sight. Professionals can accurately identify and treat diseases throughout the operation, which can take less than an hour in some cases. These procedures are also regarded a more effective usage medical resources than major surgery because they are relatively rapid. Because most outpatient processes, particularly interventional radiology, are less costly than inpatient hospital stays, patients often find interventional radiology to be a more cost-effective therapy.

Shifting preference of people towards minimally invasive procedure

Because of the benefits given by these techniques over traditional treatment processes, the demand for minimally invasive procedures has increased significantly in recent years. Fewer operating complications, shorter hospitalization, reduced pain, smaller & more cosmetic incisions, reduced risk of infection, less post-surgical care, and faster recovery are all benefits of minimally invasive procedures. Sophisticated technology is used in minimally invasive treatments to detect and cure a variety of disorders, including cancer. These treatments are intended to remove malignant tumours and lymph nodes from the body without leaving scars.

Market Restraining Factors

Restricted clinical data to maintain therapeutic efficacy

A medication must have comprehensive safety data from Phase I studies, established effectiveness from Phase II trials, and analysis of clinical results better than current therapies from randomized, controlled Phase III trials before it can be introduced as a standard of care. In addition, performing well-controlled clinical trials in interventional oncology procedures, on the other hand, is challenging owing to a dearth of recognized methodology. Chemoembolization, for example, is the most common treatment for hepatocellular cancer. On the other hand, the clinical evidence for chemoembolization is inadequate, and the clinical advantages generated from current trials are smaller than those derived from other cancer treatment alternatives.

Cancer Type Outlook

Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. The liver cancer segment witnessed the maximum revenue share in the interventional oncology market in 2021. Primary liver tumours caused by metastatic cancer can be successfully treated using interventional oncology techniques. Increased research/development efforts using interventional oncology to improve liver cancer therapy, and an increase in the number of instances of liver cancer in the world, are among the factors driving liver sub-growth.

Product Type Outlook

Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. The Ablation devices segment acquired a significant revenue share in the interventional oncology market in 2021. Because of the expanding popularity of minimally invasive treatments and the rising frequency of certain soft tissue malignancies, ablation devices provide a minimally invasive option to conventional surgical treatment of liver, kidney, prostate, and lung cancers.

End User Outlook

Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Hospitals segment acquired the highest revenue share in the interventional oncology market in 2021. The hospital sub-segment might benefit greatly from advancements in healthcare infrastructure and a boom in the adoption of innovative interventional oncology technologies like embolization and ablation devices in hospitals. Additionally, several patients prefer to undergo cancer treatment from hospitals because numerous innovative treatment facilities are housed under one roof, and patients do not have to worry about their treatment.

Interventional Oncology Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 1.9 Billion
Market size forecast in 2028	USD 2.9 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 6.2% from 2022 to 2028
Number of Pages	242
Number of Tables	390
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Cancer Type, Product Type, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	More efficiency and quick recovery offered by interventional oncology Shifting preference of people towards minimally invasive procedure
Restraints	Restricted clinical data to maintain therapeutic efficacy

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia Pacific recorded a significant revenue share in the interventional oncology market in 2021. This is due to a variety of variables, including an increase in cancer cases amongst people and improved healthcare facilities. The key factors propelling the market of the APAC interventional oncology market are government efforts to raise funding, supportive regulations for the manufacture and marketing of innovative interventional oncology products, increasing healthcare expenditure, growing amount of hospitals and clinics in India and China, broadening research base all over China, India, and Japan, and the rising incidences of surgeries.

Free Valuable Insights: Global Interventional Oncology Market size to reach USD 2.9 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)

Scope of the Study

Market Segments Covered in the Report:

By Cancer Type

• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Bone Metastasis
• Others

By Product Type

• Embolization Devices
• Ablation Devices
• Support Devices

By End User

• Hospitals
• Ambulatory Surgery Centers
• Research & Academic Institutes

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Boston Scientific Corporation
• Teleflex, Inc.
• Cook Medical, Inc. (Cook Group)
• Medtronic PLC
• Terumo Corporation
• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• Becton, Dickinson and Company
• AngioDynamics, Inc.
• Merit Medical Systems, Inc.
• HealthTronics, Inc. (Altaris Capital Partners, LLC)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Interventional Oncology Market, by Cancer Type
1.4.2 Global Interventional Oncology Market, by Product Type
1.4.3 Global Interventional Oncology Market, by End User
1.4.4 Global Interventional Oncology Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Interventional Oncology Market by Cancer Type
3.1 Global Liver Cancer Market by Region
3.2 Global Lung Cancer Market by Region
3.3 Global Kidney Cancer Market by Region
3.4 Global Breast Cancer Market by Region
3.5 Global Prostate Cancer Market by Region
3.6 Global Bone Metastasis Market by Region
3.7 Global Others Market by Region

Chapter 4. Global Interventional Oncology Market by Product Type
4.1 Global Embolization Devices Market by Region
4.2 Global Ablation Devices Market by Region
4.3 Global Support Devices Market by Region

Chapter 5. Global Interventional Oncology Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Ambulatory Surgery Centers Market by Region
5.3 Global Research & Academic Institutes Market by Region

Chapter 6. Global Interventional Oncology Market by Region
6.1 North America Interventional Oncology Market
6.1.1 North America Interventional Oncology Market by Cancer Type
6.1.1.1 North America Liver Cancer Market by Country
6.1.1.2 North America Lung Cancer Market by Country
6.1.1.3 North America Kidney Cancer Market by Country
6.1.1.4 North America Breast Cancer Market by Country
6.1.1.5 North America Prostate Cancer Market by Country
6.1.1.6 North America Bone Metastasis Market by Country
6.1.1.7 North America Others Market by Country
6.1.2 North America Interventional Oncology Market by Product Type
6.1.2.1 North America Embolization Devices Market by Country
6.1.2.2 North America Ablation Devices Market by Country
6.1.2.3 North America Support Devices Market by Country
6.1.3 North America Interventional Oncology Market by End User
6.1.3.1 North America Hospitals Market by Country
6.1.3.2 North America Ambulatory Surgery Centers Market by Country
6.1.3.3 North America Research & Academic Institutes Market by Country
6.1.4 North America Interventional Oncology Market by Country
6.1.4.1 US Interventional Oncology Market
6.1.4.1.1 US Interventional Oncology Market by Cancer Type
6.1.4.1.2 US Interventional Oncology Market by Product Type
6.1.4.1.3 US Interventional Oncology Market by End User
6.1.4.2 Canada Interventional Oncology Market
6.1.4.2.1 Canada Interventional Oncology Market by Cancer Type
6.1.4.2.2 Canada Interventional Oncology Market by Product Type
6.1.4.2.3 Canada Interventional Oncology Market by End User
6.1.4.3 Mexico Interventional Oncology Market
6.1.4.3.1 Mexico Interventional Oncology Market by Cancer Type
6.1.4.3.2 Mexico Interventional Oncology Market by Product Type
6.1.4.3.3 Mexico Interventional Oncology Market by End User
6.1.4.4 Rest of North America Interventional Oncology Market
6.1.4.4.1 Rest of North America Interventional Oncology Market by Cancer Type
6.1.4.4.2 Rest of North America Interventional Oncology Market by Product Type
6.1.4.4.3 Rest of North America Interventional Oncology Market by End User
6.2 Europe Interventional Oncology Market
6.2.1 Europe Interventional Oncology Market by Cancer Type
6.2.1.1 Europe Liver Cancer Market by Country
6.2.1.2 Europe Lung Cancer Market by Country
6.2.1.3 Europe Kidney Cancer Market by Country
6.2.1.4 Europe Breast Cancer Market by Country
6.2.1.5 Europe Prostate Cancer Market by Country
6.2.1.6 Europe Bone Metastasis Market by Country
6.2.1.7 Europe Others Market by Country
6.2.2 Europe Interventional Oncology Market by Product Type
6.2.2.1 Europe Embolization Devices Market by Country
6.2.2.2 Europe Ablation Devices Market by Country
6.2.2.3 Europe Support Devices Market by Country
6.2.3 Europe Interventional Oncology Market by End User
6.2.3.1 Europe Hospitals Market by Country
6.2.3.2 Europe Ambulatory Surgery Centers Market by Country
6.2.3.3 Europe Research & Academic Institutes Market by Country
6.2.4 Europe Interventional Oncology Market by Country
6.2.4.1 Germany Interventional Oncology Market
6.2.4.1.1 Germany Interventional Oncology Market by Cancer Type
6.2.4.1.2 Germany Interventional Oncology Market by Product Type
6.2.4.1.3 Germany Interventional Oncology Market by End User
6.2.4.2 UK Interventional Oncology Market
6.2.4.2.1 UK Interventional Oncology Market by Cancer Type
6.2.4.2.2 UK Interventional Oncology Market by Product Type
6.2.4.2.3 UK Interventional Oncology Market by End User
6.2.4.3 France Interventional Oncology Market
6.2.4.3.1 France Interventional Oncology Market by Cancer Type
6.2.4.3.2 France Interventional Oncology Market by Product Type
6.2.4.3.3 France Interventional Oncology Market by End User
6.2.4.4 Russia Interventional Oncology Market
6.2.4.4.1 Russia Interventional Oncology Market by Cancer Type
6.2.4.4.2 Russia Interventional Oncology Market by Product Type
6.2.4.4.3 Russia Interventional Oncology Market by End User
6.2.4.5 Spain Interventional Oncology Market
6.2.4.5.1 Spain Interventional Oncology Market by Cancer Type
6.2.4.5.2 Spain Interventional Oncology Market by Product Type
6.2.4.5.3 Spain Interventional Oncology Market by End User
6.2.4.6 Italy Interventional Oncology Market
6.2.4.6.1 Italy Interventional Oncology Market by Cancer Type
6.2.4.6.2 Italy Interventional Oncology Market by Product Type
6.2.4.6.3 Italy Interventional Oncology Market by End User
6.2.4.7 Rest of Europe Interventional Oncology Market
6.2.4.7.1 Rest of Europe Interventional Oncology Market by Cancer Type
6.2.4.7.2 Rest of Europe Interventional Oncology Market by Product Type
6.2.4.7.3 Rest of Europe Interventional Oncology Market by End User
6.3 Asia Pacific Interventional Oncology Market
6.3.1 Asia Pacific Interventional Oncology Market by Cancer Type
6.3.1.1 Asia Pacific Liver Cancer Market by Country
6.3.1.2 Asia Pacific Lung Cancer Market by Country
6.3.1.3 Asia Pacific Kidney Cancer Market by Country
6.3.1.4 Asia Pacific Breast Cancer Market by Country
6.3.1.5 Asia Pacific Prostate Cancer Market by Country
6.3.1.6 Asia Pacific Bone Metastasis Market by Country
6.3.1.7 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Interventional Oncology Market by Product Type
6.3.2.1 Asia Pacific Embolization Devices Market by Country
6.3.2.2 Asia Pacific Ablation Devices Market by Country
6.3.2.3 Asia Pacific Support Devices Market by Country
6.3.3 Asia Pacific Interventional Oncology Market by End User
6.3.3.1 Asia Pacific Hospitals Market by Country
6.3.3.2 Asia Pacific Ambulatory Surgery Centers Market by Country
6.3.3.3 Asia Pacific Research & Academic Institutes Market by Country
6.3.4 Asia Pacific Interventional Oncology Market by Country
6.3.4.1 China Interventional Oncology Market
6.3.4.1.1 China Interventional Oncology Market by Cancer Type
6.3.4.1.2 China Interventional Oncology Market by Product Type
6.3.4.1.3 China Interventional Oncology Market by End User
6.3.4.2 Japan Interventional Oncology Market
6.3.4.2.1 Japan Interventional Oncology Market by Cancer Type
6.3.4.2.2 Japan Interventional Oncology Market by Product Type
6.3.4.2.3 Japan Interventional Oncology Market by End User
6.3.4.3 India Interventional Oncology Market
6.3.4.3.1 India Interventional Oncology Market by Cancer Type
6.3.4.3.2 India Interventional Oncology Market by Product Type
6.3.4.3.3 India Interventional Oncology Market by End User
6.3.4.4 South Korea Interventional Oncology Market
6.3.4.4.1 South Korea Interventional Oncology Market by Cancer Type
6.3.4.4.2 South Korea Interventional Oncology Market by Product Type
6.3.4.4.3 South Korea Interventional Oncology Market by End User
6.3.4.5 Singapore Interventional Oncology Market
6.3.4.5.1 Singapore Interventional Oncology Market by Cancer Type
6.3.4.5.2 Singapore Interventional Oncology Market by Product Type
6.3.4.5.3 Singapore Interventional Oncology Market by End User
6.3.4.6 Malaysia Interventional Oncology Market
6.3.4.6.1 Malaysia Interventional Oncology Market by Cancer Type
6.3.4.6.2 Malaysia Interventional Oncology Market by Product Type
6.3.4.6.3 Malaysia Interventional Oncology Market by End User
6.3.4.7 Rest of Asia Pacific Interventional Oncology Market
6.3.4.7.1 Rest of Asia Pacific Interventional Oncology Market by Cancer Type
6.3.4.7.2 Rest of Asia Pacific Interventional Oncology Market by Product Type
6.3.4.7.3 Rest of Asia Pacific Interventional Oncology Market by End User
6.4 LAMEA Interventional Oncology Market
6.4.1 LAMEA Interventional Oncology Market by Cancer Type
6.4.1.1 LAMEA Liver Cancer Market by Country
6.4.1.2 LAMEA Lung Cancer Market by Country
6.4.1.3 LAMEA Kidney Cancer Market by Country
6.4.1.4 LAMEA Breast Cancer Market by Country
6.4.1.5 LAMEA Prostate Cancer Market by Country
6.4.1.6 LAMEA Bone Metastasis Market by Country
6.4.1.7 LAMEA Others Market by Country
6.4.2 LAMEA Interventional Oncology Market by Product Type
6.4.2.1 LAMEA Embolization Devices Market by Country
6.4.2.2 LAMEA Ablation Devices Market by Country
6.4.2.3 LAMEA Support Devices Market by Country
6.4.3 LAMEA Interventional Oncology Market by End User
6.4.3.1 LAMEA Hospitals Market by Country
6.4.3.2 LAMEA Ambulatory Surgery Centers Market by Country
6.4.3.3 LAMEA Research & Academic Institutes Market by Country
6.4.4 LAMEA Interventional Oncology Market by Country
6.4.4.1 Brazil Interventional Oncology Market
6.4.4.1.1 Brazil Interventional Oncology Market by Cancer Type
6.4.4.1.2 Brazil Interventional Oncology Market by Product Type
6.4.4.1.3 Brazil Interventional Oncology Market by End User
6.4.4.2 Argentina Interventional Oncology Market
6.4.4.2.1 Argentina Interventional Oncology Market by Cancer Type
6.4.4.2.2 Argentina Interventional Oncology Market by Product Type
6.4.4.2.3 Argentina Interventional Oncology Market by End User
6.4.4.3 UAE Interventional Oncology Market
6.4.4.3.1 UAE Interventional Oncology Market by Cancer Type
6.4.4.3.2 UAE Interventional Oncology Market by Product Type
6.4.4.3.3 UAE Interventional Oncology Market by End User
6.4.4.4 Saudi Arabia Interventional Oncology Market
6.4.4.4.1 Saudi Arabia Interventional Oncology Market by Cancer Type
6.4.4.4.2 Saudi Arabia Interventional Oncology Market by Product Type
6.4.4.4.3 Saudi Arabia Interventional Oncology Market by End User
6.4.4.5 South Africa Interventional Oncology Market
6.4.4.5.1 South Africa Interventional Oncology Market by Cancer Type
6.4.4.5.2 South Africa Interventional Oncology Market by Product Type
6.4.4.5.3 South Africa Interventional Oncology Market by End User
6.4.4.6 Nigeria Interventional Oncology Market
6.4.4.6.1 Nigeria Interventional Oncology Market by Cancer Type
6.4.4.6.2 Nigeria Interventional Oncology Market by Product Type
6.4.4.6.3 Nigeria Interventional Oncology Market by End User
6.4.4.7 Rest of LAMEA Interventional Oncology Market
6.4.4.7.1 Rest of LAMEA Interventional Oncology Market by Cancer Type
6.4.4.7.2 Rest of LAMEA Interventional Oncology Market by Product Type
6.4.4.7.3 Rest of LAMEA Interventional Oncology Market by End User

Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Regional Analysis
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations and Agreements:
7.5.5.2 Acquisitions and Mergers:
7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Becton, Dickinson and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 AngioDynamics, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Merit Medical Systems, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.10.1 Company Overview

TABLE 1 Global Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 2 Global Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 3 Global Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 4 Global Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 5 Global Liver Cancer Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Liver Cancer Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Lung Cancer Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Lung Cancer Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Kidney Cancer Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Kidney Cancer Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Breast Cancer Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Breast Cancer Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Prostate Cancer Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Prostate Cancer Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Bone Metastasis Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Bone Metastasis Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 20 Global Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 21 Global Embolization Devices Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Embolization Devices Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Ablation Devices Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Ablation Devices Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Support Devices Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Support Devices Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 28 Global Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 29 Global Hospitals Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Hospitals Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Ambulatory Surgery Centers Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Ambulatory Surgery Centers Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Research & Academic Institutes Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Research & Academic Institutes Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Interventional Oncology Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Interventional Oncology Market by Region, 2022 - 2028, USD Million
TABLE 37 North America Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 38 North America Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 39 North America Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 40 North America Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 41 North America Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 56 North America Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 57 North America Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 64 North America Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 65 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 73 US Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 74 US Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 75 US Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 76 US Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 77 US Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 78 US Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 79 US Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 80 US Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 81 Canada Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 82 Canada Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 83 Canada Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 84 Canada Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 85 Canada Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 86 Canada Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 87 Canada Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 88 Canada Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 89 Mexico Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 90 Mexico Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 91 Mexico Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 92 Mexico Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 93 Mexico Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 94 Mexico Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 95 Mexico Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 96 Mexico Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 97 Rest of North America Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 98 Rest of North America Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 99 Rest of North America Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 100 Rest of North America Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 101 Rest of North America Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 102 Rest of North America Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 103 Rest of North America Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 104 Rest of North America Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 105 Europe Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 106 Europe Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 107 Europe Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 108 Europe Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 109 Europe Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 124 Europe Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 125 Europe Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 126 Europe Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 127 Europe Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 132 Europe Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 133 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 136 Europe Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 137 Europe Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 141 Germany Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 142 Germany Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 143 Germany Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 144 Germany Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 145 Germany Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 146 Germany Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 147 Germany Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 148 Germany Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 149 UK Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 150 UK Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 151 UK Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 152 UK Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 153 UK Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 154 UK Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 155 UK Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 156 UK Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 157 France Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 158 France Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 159 France Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 160 France Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 161 France Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 162 France Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 163 France Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 164 France Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 165 Russia Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 166 Russia Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 167 Russia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 168 Russia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 169 Russia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 170 Russia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 171 Russia Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 172 Russia Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 173 Spain Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 174 Spain Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 175 Spain Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 176 Spain Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 177 Spain Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 178 Spain Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 179 Spain Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 180 Spain Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 181 Italy Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 182 Italy Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 183 Italy Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 184 Italy Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 185 Italy Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 186 Italy Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 187 Italy Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 188 Italy Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 189 Rest of Europe Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 190 Rest of Europe Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 191 Rest of Europe Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 192 Rest of Europe Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 193 Rest of Europe Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 194 Rest of Europe Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 195 Rest of Europe Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 196 Rest of Europe Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 209 Asia Pacific Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 210 Asia Pacific Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 211 Asia Pacific Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 215 Asia Pacific Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 216 Asia Pacific Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 217 Asia Pacific Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 218 Asia Pacific Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 219 Asia Pacific Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 220 Asia Pacific Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 221 Asia Pacific Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 222 Asia Pacific Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 223 Asia Pacific Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 224 Asia Pacific Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 225 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 226 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 227 Asia Pacific Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 228 Asia Pacific Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 229 Asia Pacific Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 230 Asia Pacific Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 231 Asia Pacific Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 232 Asia Pacific Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 233 China Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 234 China Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 235 China Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 236 China Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 237 China Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 238 China Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 239 China Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 240 China Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 241 Japan Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 242 Japan Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 243 Japan Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 244 Japan Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 245 Japan Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 246 Japan Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 247 Japan Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 248 Japan Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 249 India Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 250 India Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 251 India Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 252 India Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 253 India Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 254 India Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 255 India Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 256 India Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 257 South Korea Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 258 South Korea Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 259 South Korea Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 260 South Korea Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 261 South Korea Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 262 South Korea Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 263 South Korea Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 264 South Korea Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 265 Singapore Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 266 Singapore Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 267 Singapore Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 268 Singapore Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 269 Singapore Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 270 Singapore Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 271 Singapore Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 272 Singapore Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 273 Malaysia Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 274 Malaysia Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 275 Malaysia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 276 Malaysia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 277 Malaysia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 278 Malaysia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 279 Malaysia Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 280 Malaysia Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 281 Rest of Asia Pacific Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 282 Rest of Asia Pacific Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 283 Rest of Asia Pacific Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 284 Rest of Asia Pacific Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 285 Rest of Asia Pacific Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 286 Rest of Asia Pacific Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 287 Rest of Asia Pacific Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 288 Rest of Asia Pacific Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 289 LAMEA Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 290 LAMEA Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 291 LAMEA Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 292 LAMEA Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 293 LAMEA Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 295 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 296 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 297 LAMEA Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 298 LAMEA Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 299 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 300 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 301 LAMEA Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 302 LAMEA Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 303 LAMEA Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 304 LAMEA Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 305 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 306 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 307 LAMEA Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 308 LAMEA Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 309 LAMEA Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 310 LAMEA Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 311 LAMEA Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 312 LAMEA Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 313 LAMEA Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 314 LAMEA Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 315 LAMEA Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 316 LAMEA Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 317 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 318 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 319 LAMEA Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 320 LAMEA Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 321 LAMEA Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 322 LAMEA Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 323 LAMEA Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 324 LAMEA Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 325 Brazil Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 326 Brazil Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 327 Brazil Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 328 Brazil Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 329 Brazil Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 330 Brazil Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 331 Brazil Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 332 Brazil Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 333 Argentina Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 334 Argentina Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 335 Argentina Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 336 Argentina Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 337 Argentina Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 338 Argentina Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 339 Argentina Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 340 Argentina Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 341 UAE Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 342 UAE Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 343 UAE Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 344 UAE Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 345 UAE Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 346 UAE Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 347 UAE Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 348 UAE Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 349 Saudi Arabia Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 350 Saudi Arabia Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 351 Saudi Arabia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 352 Saudi Arabia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 353 Saudi Arabia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 354 Saudi Arabia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 355 Saudi Arabia Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 356 Saudi Arabia Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 357 South Africa Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 358 South Africa Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 359 South Africa Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 360 South Africa Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 361 South Africa Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 362 South Africa Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 363 South Africa Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 364 South Africa Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 365 Nigeria Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 366 Nigeria Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 367 Nigeria Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 368 Nigeria Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 369 Nigeria Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 370 Nigeria Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 371 Nigeria Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 372 Nigeria Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 373 Rest of LAMEA Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 374 Rest of LAMEA Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 375 Rest of LAMEA Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 376 Rest of LAMEA Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 377 Rest of LAMEA Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 378 Rest of LAMEA Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 379 Rest of LAMEA Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 380 Rest of LAMEA Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 381 key Information – Boston Scientific Corporation
TABLE 382 key Information – Teleflex, Inc.
TABLE 383 key Information – Cook Medical, Inc.
TABLE 384 Key Information – Medtronic PLC
TABLE 385 Key Information – Terumo Corporation
TABLE 386 Key information – Johnson & Johnson
TABLE 387 Key information – Becton, Dickinson and Company
TABLE 388 Key Information – AngioDynamics, Inc.
TABLE 389 Key Information – Merit Medical Systems, Inc.
TABLE 390 Key Information – HealthTronics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Interventional Oncology Market share by Cancer Type, 2021
FIG 3 Global Interventional Oncology Market share by Cancer Type, 2028
FIG 4 Global Interventional Oncology Market by Cancer Type, 2018 - 2028, USD Million
FIG 5 Global Interventional Oncology Market share by Product Type, 2021
FIG 6 Global Interventional Oncology Market share by Product Type, 2028
FIG 7 Global Interventional Oncology Market by Product Type, 2018 - 2028, USD Million
FIG 8 Global Interventional Oncology Market share by End User, 2021
FIG 9 Global Interventional Oncology Market share by End User, 2028
FIG 10 Global Interventional Oncology Market by End User, 2018 - 2028, USD Million
FIG 11 Global Interventional Oncology Market share by Region, 2021
FIG 12 Global Interventional Oncology Market share by Region, 2028
FIG 13 Global Interventional Oncology Market by Region, 2018 - 2028, USD Million
FIG 14 SWOT Analysis: Boston Scientific Corporation
FIG 15 Swot analysis: Medtronic plc
FIG 16 SWOT analysis: Johnson & Johnson
FIG 17 Swot analysis: Becton, Dickinson and company